First Alzheimer's drug to slow disease progression gets full FDA approval, triggering broader Medicare coverage
(CNN) --- The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer's drug Leqembi, the first medicine proven to slow the course of the mem…
